Acidification treatment method of glycerol, acidified glycerol and application of acidified glycerol

By acidizing glycerol treatment and adding hydroxypropylmethylcellulose, the formulation of lomefloxacin hydrochloride ear drops was optimized, and the problem of insufficient stability of drugs in the prior art under high temperature and light conditions was solved, which significantly improved the safety of drugs and Validity period.

CN118978426AActive Publication Date: 2024-11-19ZHEJIANG UNIV +1

Patent Information

Application Number
CN202411474332.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-22
Publication Date
2024-11-19
Estimated Expiration
2044-10-22

AI Technical Summary

Technical Problem

The stability of the existing lomefloxacin hydrochloride ear drop liquid is insufficient under high temperature and light conditions, which affects the safety and effectiveness of the drug.

Method used

The composition formula is optimized to improve stability by treating activated carbon with hydrochloric acid and mixing with glycerol, heating and filtration, and adding acidified glycerol and hydroxypropylmethylcellulose to the lomefloxacin hydrochloride ear drops.

Benefits of technology

It significantly improves the stability of the drug under high temperature and light conditions, extends the validity period, enhances the safety and retention time of the drug, and reduces storage and transportation conditions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The invention relates to the technical field of medicines, in particular to an acidizing treatment method of glycerol, acidized glycerol and application of the acidized glycerol. The glycerol acidizing treatment method comprises the following steps: firstly, adding hydrochloric acid into activated carbon for treatment, and drying; and adding the activated carbon treated in the step (1) into glycerol, heating, and filtering to obtain the product. The acidified glycerol prepared by the acidizing treatment method has a remarkable effect in the aspect of improving the drug stability. A certain proportion of hydroxypropyl methylcellulose (E3) is further added, the stability of the medicine at the high temperature of 60 DEG C and under the illumination condition can be further improved, and the medicine has a good application prospect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of medicines, and in particular to a method for acidifying glycerol, acidified glycerol and applications thereof. Background Art

[0002] Lomefloxacin hydrochloride is a third-generation broad-spectrum quinolone antibiotic, which has high antibacterial activity against Enterobacteriaceae such as Escherichia coli, Shigella, Klebsiella, Proteus, Enterobacter, etc.; Haemophilus influenzae, Neisseria gonorrhoeae, etc. are also highly sensitive to this product; it also has certain antibacterial effects on Pseudomonas, such as Acinetobacter and Pseudomonas aeruginosa, Staphylococcus, Pneumococcus, and hemolytic Streptococcus.

[0003] Lomefloxacin hydrochloride has a long half-life, lasting effect, and good permeability. Ethanol is usually added to the marketed preparations of lomefloxacin hydrochloride ear drops to increase the solubility and permeability of the drug, help the drug act on the inflammatory site, and have a certain degree of irritation. Glycerin can alleviate the irritation of ethanol to the mucosa and prolong the local retention time of the drug. Lomefloxacin hydrochloride ear drops are weakly acidic. The Chinese New Drug Standard (No.: WS1-(X-034)-2002Z) stipulates that pH 4.5-6.0 has good stability and safety, and meets all the quality requirements of ear drops. Through research on the lomefloxacin hydrochloride ear drops that have been marketed in China, it is found that the packaging is a low-density polyethylene medicinal eye drop bottle, all of which are light-shielded and airtightly stored with a shelf life of 24 months.

[0004] After searching the literature in many countries, it was found that there were only optimization of formulation process and quality research, but no research on improvement of product stability.

[0005] The Chinese invention patent application CN109260152A of Yuzhou Traditional Chinese Medicine Hospital discloses a lomefloxacin hydrochloride ear drop solution, which uses hydrogenated castor oil and polyethylene glycol as cosolvents, glycerol as a penetration enhancer, and disodium ethylenediaminetetraacetic acid as a buffer. The lomefloxacin hydrochloride ear drop solution can self-aggregate to form a micellar solution, which not only reduces the irritation of the ear drops and the patient's discomfort, but also prolongs the retention time in the ear. However, the above-mentioned are all commonly used functional excipients, and the product stability needs to be further improved. Summary of the invention

[0006] In view of the deficiencies in the prior art, the present invention provides a method for acidifying glycerol, acidified glycerol and applications.

[0007] The objective of the present invention is achieved through the following technical solutions: A method for acidifying glycerol comprises the following steps: (1) Add hydrochloric acid to the activated carbon and dry it; (2) Add the activated carbon treated in step (1) into glycerol, heat, and filter to obtain the product.

[0008] Preferably, the concentration of the hydrochloric acid in step (1) is 0.05-2 mol / L, and the mass volume ratio of the activated carbon to the hydrochloric acid is 1-1.5 g:10 mL.

[0009] Preferably, the treatment in step (1) is first boiling and then stirring at 70-80°C.

[0010] Preferably, the boiling time is 10-15 minutes.

[0011] Preferably, the stirring time is 40-60 minutes.

[0012] Preferably, cooling and filtration are performed before drying in step (1).

[0013] Preferably, the glycerol in step (2) is 0.3%-0.5% of the mass of the activated carbon treated in step (1).

[0014] Preferably, the heating in step (2) is heating to 80°C-100°C and then stirring for 15-20 minutes.

[0015] Another object of the present invention is to provide acidified glycerol prepared by the above acidification treatment method.

[0016] The third object of the present invention is to provide a lomefloxacin hydrochloride ear drop composition, which comprises lomefloxacin hydrochloride, acidified glycerol, disodium edetate, hypromellose and ethanol.

[0017] Preferably, the mass ratio of lomefloxacin hydrochloride to hypromellose is 3-4:5-12; more preferably 3.3:5-3.3:12.

[0018] Preferably, the composition comprises, by weight, 1-10 parts of lomefloxacin hydrochloride, 150-350 parts of acidified glycerol, 0.1-2 parts of disodium edetate, 1-15 parts of hypromellose and 150-400 parts of ethanol.

[0019] Preferably, the composition comprises, by weight, 3-7 parts of lomefloxacin hydrochloride, 150-350 parts of acidified glycerol, 0.5-1 part of disodium edetate, 5-12 parts of hypromellose and 150-400 parts of ethanol.

[0020] Preferably, the hypromellose is hypromellose E3.

[0021] The fourth object of the present invention is to provide a method for preparing the lomefloxacin hydrochloride ear drops composition, comprising the following steps: (1) Heat water, add lomefloxacin hydrochloride to dissolve, and then add edetate disodium and hypromellose to dissolve; (2) mixing acidified glycerol and ethanol, and adding the mixture to the solution system of step (1); (3) Add water to make up the volume so that the solution contains 3.3-6.7 mg / ml of lomefloxacin hydrochloride, and filter to obtain the solution.

[0022] Preferably, the temperature in step (1) is heated to 40-50° C., and in step (3) water is added to make the volume constant so that the solution contains 3.3-6.7 mg / ml of lomefloxacin hydrochloride.

[0023] The fifth object of the present invention is to provide the use of the acidified glycerol prepared by the above-mentioned acidification treatment method in improving the stability of drugs.

[0024] Compared with the prior art, the present invention has the following beneficial effects: (1) After extensive research, the inventor unexpectedly discovered that special acidification of glycerol and then adding it to the drug can significantly improve the stability of the drug.

[0025] (2) The present invention further adds a certain proportion of hydroxypropyl methylcellulose (E3) to further improve the stability of the product. Glycerin may contain some metal ions or impurities that affect the stability of the product. Through this treatment, the stability is greatly improved. The addition of hydroxypropyl methylcellulose can increase the viscosity and increase the retention time at the administration site. At the same time, due to the increase in viscosity, it can also reduce the transmittance of light. Under the dual effects, the stability of the product under light and high temperature can be increased at the same time. However, similar excipients cannot achieve similar effects.

[0026] (3) The stability of the product prepared by the present invention is greatly improved, and the stability is significantly improved under high temperature of 60°C and light conditions; the safety of product medication is improved, and the patient compliance is improved.

[0027] (4) The present invention can also reduce storage and transportation conditions, increase the shelf life, and thus reduce costs. DETAILED DESCRIPTION

[0028] The present invention will be further described below in conjunction with specific implementation modes.

[0029] The following raw materials are all conventional raw materials in the art, among which the models and manufacturers of the raw and auxiliary materials of lomefloxacin hydrochloride ear drops are shown in Table 1.

[0030] Table 1 Information on raw and auxiliary materials used in each example Name of raw materials Manufacturer Lomefloxacin hydrochloride Yichang Renfu Pharmaceutical Co., Ltd. glycerin Jilin Aodong Biotechnology Co., Ltd. Ethanol Nanjing Chemical Reagent Co., Ltd. Edetate Disodium Hunan Erkang Pharmaceutical Co., Ltd. Hydroxypropyl methylcellulose E3 Hunan Erkang Pharmaceutical Co., Ltd. Povidone K30 BASF New Materials Co., Ltd. Hydroxypropyl methylcellulose E5 Hunan Erkang Pharmaceutical Co., Ltd. hydrochloric acid Nanjing Chemical Reagent Co., Ltd. Activated carbon Zhejiang Xingda Activated Carbon Co., Ltd. Example 1 Acidification method of glycerol: (1) Activated carbon treatment: Add 10g activated carbon to 100ml 0.1mol / L hydrochloric acid, boil for 15 minutes, stir at 75℃ for 40 minutes, cool and filter, and then dry for later use; (2) Add 0.3% of the weight of glycerol to the treated activated carbon while stirring the glycerol, heat to 85±2°C, stir for 15 minutes, cool and filter to obtain acidified glycerol for later use.

[0031] The composition formula of lomefloxacin hydrochloride ear drops is as shown in Table 2: Table 2 Example 1 Lomefloxacin hydrochloride ear drops composition formula

[0032] Preparation method of lomefloxacin hydrochloride ear drops composition: (1) Weigh an appropriate amount of water (100 g) and heat it to 45°C. Add the prescribed amount of lomefloxacin hydrochloride and stir to dissolve. Then add the prescribed amount of edetate disodium and hypromellose in turn and dissolve for later use. (2) Evenly mix the prescribed amount of acidified glycerol and the prescribed amount of ethanol, then add the solution obtained in (1) and stir evenly; (3) Add purified water to make up to 1000 ml; (4) Filtration: 0.45 μm filter membrane; (5) Filling: 5 ml / tube; (6) Seal.

[0033] Example 2 Acidification method of glycerol: (1) Activated carbon treatment: Add 10g activated carbon to 100ml 0.1mol / L hydrochloric acid, boil for 10 minutes, stir at 80℃ for 60 minutes, cool and filter, and then dry for later use; (2) Add 0.5% of the treated activated carbon to the glycerol under stirring, heat to 95±2°C, stir for 20 minutes, cool and filter to obtain acidified glycerol for later use.

[0034] The composition formula of lomefloxacin hydrochloride ear drops is as shown in Table 3: Table 3 Example 2 Lomefloxacin hydrochloride ear drops composition formula

[0035] Preparation method of lomefloxacin hydrochloride ear drops composition: (1) Weigh an appropriate amount of water (about 100 g) and heat it to 50°C, add the prescribed amount of lomefloxacin hydrochloride, stir to dissolve, then add the prescribed amount of edetate disodium and hypromellose in sequence and dissolve for later use; (2) Evenly mix the prescribed amount of acidified glycerol and the prescribed amount of ethanol, then add the solution obtained in (1) and stir evenly; (3) Add purified water to make up to 1000 ml; (4) Filtration: 0.45 μm filter membrane; (5) Filling: 5 ml / tube; (6) Seal.

[0036] Example 3 Acidification method of glycerol: (1) Activated carbon treatment: Add 10g activated carbon to 100ml 0.1mol / L hydrochloric acid, boil for 10 minutes, stir at 70℃ for 60 minutes, cool and filter, and then dry for later use; (2) Add 0.5% of the treated activated carbon to the glycerol while stirring, heat to 95±2°C, stir for 20 minutes, cool and filter to obtain acidified glycerol for later use; The composition formula of lomefloxacin hydrochloride ear drops is as shown in Table 4: Table 4 Example 3 Lomefloxacin hydrochloride ear drops composition formula

[0037] Preparation method of lomefloxacin hydrochloride ear drops composition: (1) Weigh an appropriate amount of water (about 100 g) and heat it to 40°C, add the prescribed amount of lomefloxacin hydrochloride, stir to dissolve, then add the prescribed amount of edetate disodium and hypromellose in sequence and dissolve for later use; (2) Evenly mix the prescribed amount of acidified glycerol and the prescribed amount of ethanol, then add the solution obtained in (1) and stir evenly; (3) Add purified water to make up to 1000 ml; (4) Filtration: 0.45 μm filter membrane; (5) Filling: 5 ml / tube; (6) Seal.

[0038] Example 4 Acidification method of glycerol: (1) Activated carbon treatment: Add 15g activated carbon to 100ml 0.1mol / L hydrochloric acid, boil for 10 minutes, stir at 75℃ for 60 minutes, cool, filter, and dry for later use; (2) Add 0.5% of the treated activated carbon to the glycerol while stirring, heat to 95±2°C, stir for 20 minutes, cool and filter to obtain acidified glycerol for later use; The composition formula of lomefloxacin hydrochloride ear drops is as shown in Table 5: Table 5 Example 4 Lomefloxacin hydrochloride ear drops composition formula

[0039] Preparation method of lomefloxacin hydrochloride ear drops composition: (1) Weigh an appropriate amount of water (about 100 g) and heat it to 45°C. Add the prescribed amount of lomefloxacin hydrochloride and stir to dissolve. Then add the prescribed amount of edetate disodium and hypromellose in turn and dissolve for later use. (2) Evenly mix the prescribed amount of acidified glycerol and the prescribed amount of ethanol, then add the solution obtained in (1) and stir evenly; (3) Add purified water to make up to 1000 ml; (4) Filling: 10 ml / tube; (5) Seal.

[0040] Example 5 Acidification method of glycerol: (1) Activated carbon treatment: Add 15g activated carbon to 100ml 0.1mol / L hydrochloric acid, boil for 10 minutes, stir at 80℃ for 60 minutes, cool, filter, and dry for later use; (2) Add 0.5% of the treated activated carbon to the glycerol under stirring, heat to 95±2°C, stir for 20 minutes, cool and filter to obtain acidified glycerol for later use.

[0041] The composition formula of lomefloxacin hydrochloride ear drops is as shown in Table 6: Table 6 Example 5 Lomefloxacin hydrochloride ear drops composition formula

[0042] Preparation method of lomefloxacin hydrochloride ear drops composition: (1) Weigh an appropriate amount of water (about 100 g) and heat it to 50°C, add the prescribed amount of lomefloxacin hydrochloride, stir to dissolve, then add the prescribed amount of edetate disodium and hypromellose in sequence and dissolve for later use; (2) Evenly mix the prescribed amount of acidified glycerol and the prescribed amount of ethanol, then add the solution obtained in (1) and stir evenly; (3) Add purified water to make up to 1000 ml; (4) Filtration: 0.45 μm filter membrane; (5) Filling: 10 ml / tube; (6) Seal.

[0043] Comparative Example 1 The only difference from Example 1 is that the glycerol is not acidified.

[0044] Comparative Example 2 The difference from Example 1 is that in the acidification treatment method of glycerol, step (1) the activated carbon treatment is boiled for 5 minutes.

[0045] Comparative Example 3 The difference from Example 1 is that in the acidification treatment method of glycerol, step (1) the activated carbon treatment is boiled for 20 minutes; Comparative Example 4 The difference from Example 1 is that in the acidification treatment method of glycerol, the amount of activated carbon in step (1) is 6 g.

[0046] Comparative Example 5 The difference from Example 1 is that in the acidification treatment method of glycerol, the amount of activated carbon in step (1) is 18 g.

[0047] Comparative Example 6 The only difference from Example 1 is that in the acidification treatment method of glycerol, in step (1), stirring is performed at 65° C. for 40 minutes, and filtering is performed after cooling.

[0048] Comparative Example 7 The only difference from Example 1 is that in the acidification treatment method of glycerol, in step (1), stirring is performed at 85° C. for 40 minutes, and filtering is performed after cooling.

[0049] Comparative Example 8 The only difference from Example 1 is that 0.2% of treated activated carbon is added in step (2) of the acidification treatment of glycerol.

[0050] Comparative Example 9 The only difference from Example 1 is that 0.6% of treated activated carbon is added in step (2) of the acidification treatment of glycerol.

[0051] Comparative Example 10 The difference from Example 1 is that in the acidification treatment method of glycerol, the stirring time after adding activated carbon in step (2) is 10 minutes.

[0052] Comparative Example 11 The difference from Example 1 is that in the acidification treatment method of glycerol, the stirring time after glycerol treatment of activated carbon in step (2) is 25 minutes.

[0053] Comparative Example 12 The only difference from Example 1 is that in the acidification treatment method of glycerol, the heating temperature during stirring after glycerol treatment of activated carbon in step (2) is 75°C.

[0054] Comparative Example 13 The only difference from Example 1 is that in the acidification treatment method of glycerol, the heating temperature during stirring after glycerol treatment of activated carbon in step (2) is 105°C.

[0055] Comparative Example 14 The only difference from Example 1 is that hypromellose E3 is replaced by povidone K30.

[0056] Comparative Example 15 The only difference from Example 1 is that hypromellose E3 is replaced by hypromellose E5.

[0057] Comparative Example 16 The only difference from Example 1 is that the amount of hypromellose E3 is 4 g, and the weight ratio of lomefloxacin hydrochloride to hypromellose is 3.3:4.

[0058] Comparative Example 17 The only difference from Example 4 is that the amount of hypromellose E3 is 13 g, and the weight ratio of lomefloxacin hydrochloride to hypromellose is 3.3:13.

[0059] Comparative Example 18 The difference from Example 1 is that in the method for preparing acidified glycerol, hydrochloric acid in step (1) is replaced by phosphoric acid.

[0060] Evaluation of drug stability results in each example The lomefloxacin hydrochloride ear drops obtained in Examples 1 to 5 and Comparative Examples 1 to 17 were placed under high temperature of 60°C for 10 days, 30 days, 60 days and under light (total illumination of not less than 1.2×10 6 lux·hr, near ultraviolet energy not less than 200w·hr / m 2 ) conditions for 10 days and 15 days, and observe the changes in product shape and related substances. The test results are shown in Tables 7 and 8.

[0061] Table 7 Results of the high temperature 60°C test on the finished products of each preparation

[0062]

[0063]

[0064]

[0065] For Comparative Examples 1-14 and 18, the high temperature for 60 days has exceeded the limit. For Comparative Examples 15-17, the high temperature for 60 days meets the requirement, but the light intensity does not meet the requirement.

[0066] Table 8 Results of investigation under lighting conditions for finished preparations

[0067]

[0068]

[0069] Examples 1-5 are the best examples, which are better than the control preparation in terms of high temperature and light stability. The control preparation meets the requirements at 60°C for 30 days, but 60 days exceeds the limit. Examples 1-5 still meet the requirements at 60°C for 60 days.

[0070] Comparative Examples 1-13 are glycerol treatments which are not within the scope of the patent claims, and high temperatures of 60°C for 60 days have exceeded the limit. Comparative Example 18 is glycerol treatment with hydrochloric acid analogs, and high temperatures of 60°C for 60 days have exceeded the limit. Comparative Examples 14-15 are analogs of hydroxypropyl methylcellulose E3, and high temperatures of 60°C for 60 days and light exposure for 15 days have exceeded the limit.

[0071] In Comparative Examples 16-17, the weight ratio of active ingredient to hydroxypropyl methylcellulose was outside the scope of the patent claims, and the limit was exceeded for 15 days of illumination.

[0072] The above results show that the embodiments within the scope of the claims can achieve beneficial effects, while the comparative examples and control preparations outside the scope cannot achieve good stability effects.

[0073] The above detailed description is a specific description of one feasible embodiment of the present invention. The embodiment is not intended to limit the patent scope of the present invention. Any equivalent implementation or modification that does not deviate from the present invention should be included in the scope of the technical solution of the present invention.

Claims

1. A method for acidifying glycerol, characterized in that: The steps include: (1) Add hydrochloric acid to the activated carbon and dry it to obtain the treated activated carbon; (2) Add treated activated carbon to glycerol, heat, and filter to obtain the product.

2. The acidification treatment method according to claim 1, characterized in that: The concentration of the hydrochloric acid in step (1) is 0.05-2 mol / L, and the mass volume ratio of the activated carbon to the hydrochloric acid is 1-1.5 g:10 mL.

3. The acidification treatment method according to claim 1, characterized in that: The treatment in step (1) is to first boil for 10-15 minutes and then stir at 70-80°C for 40-60 minutes.

4. The acidification treatment method according to claim 1, characterized in that: In step (2), 0.3%-0.5% of the mass of glycerol is added to the treated activated carbon; the heating is performed to 80° C.-100° C. and then stirred for 15-20 minutes.

5. Acidified glycerol prepared by the acidification method according to any one of claims 1 to 4.

6. Use of acidified glycerol prepared by the acidification method according to any one of claims 1 to 4 in improving drug stability.

7. A lomefloxacin hydrochloride ear drop composition, characterized in that: The composition comprises lomefloxacin hydrochloride, acidified glycerol, disodium edetate, hypromellose and ethanol; the acidified glycerol is prepared by the acidification treatment method according to any one of claims 1 to 4.

8. The lomefloxacin hydrochloride ear drop composition according to claim 7, characterized in that: The mass ratio of lomefloxacin hydrochloride to hypromellose is 3-4:5-12, and the hypromellose is hypromellose E3.

9. The lomefloxacin hydrochloride ear drop composition according to claim 7, characterized in that: The composition comprises, by weight, 1-10 parts of lomefloxacin hydrochloride, 150-350 parts of acidified glycerol, 0.1-2 parts of disodium edetate, 1-15 parts of hypromellose and 150-400 parts of ethanol.

10. A method for preparing the lomefloxacin hydrochloride ear drop composition according to any one of claims 7 to 9, characterized in that: The steps include: (1) Heat water to 40-50°C, add lomefloxacin hydrochloride to dissolve, and then add edetate disodium and hypromellose to dissolve; (2) mixing acidified glycerol and ethanol, and adding the mixture to the solution system of step (1); (3) Add water to make up the volume so that the solution contains 3.3-6.7 mg / ml of lomefloxacin hydrochloride, and filter to obtain the solution.

Citation Information

Patent Citations

  • Lomefloxacin aspartate compound

    CN102276582A

  • Lomefloxacin hydrochloride eye drops and preparation method and application thereof

    CN102670493A

  • Acidizing method for crude glycerine

    CN105037096A

  • Levofloxacin hydrochloride injection and preparation method thereof

    CN108685846A

  • Lomefloxacin hydrochloride ear drop

    CN109260152A

Cited By

  • Lomefloxacin hydrochloride ear drop composition as well as product, preparation method and application thereof

    CN119896636A

  • Lomefloxacin Hydrochloride Ear Drops Composition, Its Product, Preparation Method and Application

    CN119896636B